Home Other Building Blocks 1,2,3,4-Tetrahydro-1-naphthol

1,2,3,4-Tetrahydro-1-naphthol

CAS No.:
529-33-9
Catalog Number:
AG003D9Y
Molecular Formula:
C10H12O
Molecular Weight:
148.2017
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5g
98%
In Stock USA
United States
$35
- +
25g
98%
In Stock USA
United States
$125
- +
100g
98%
In Stock USA
United States
$344
- +
500g
98%
In Stock USA
United States
$1238
- +
Product Description
Catalog Number:
AG003D9Y
Chemical Name:
1,2,3,4-Tetrahydro-1-naphthol
CAS Number:
529-33-9
Molecular Formula:
C10H12O
Molecular Weight:
148.2017
MDL Number:
MFCD00001739
IUPAC Name:
1,2,3,4-tetrahydronaphthalen-1-ol
InChI:
InChI=1S/C10H12O/c11-10-7-3-5-8-4-1-2-6-9(8)10/h1-2,4,6,10-11H,3,5,7H2
InChI Key:
JAAJQSRLGAYGKZ-UHFFFAOYSA-N
SMILES:
OC1CCCc2c1cccc2
EC Number:
208-459-0
NSC Number:
5172
Properties
Complexity:
133  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
148.089g/mol
Formal Charge:
0
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
148.205g/mol
Monoisotopic Mass:
148.089g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
20.2A^2
Undefined Atom Stereocenter Count:
2  
Undefined Bond Stereocenter Count:
0
XLogP3:
1.8  
Literature
Title Journal
Gold nanoparticles incarcerated in nanoporous syndiotactic polystyrene matrices as new and efficient catalysts for alcohol oxidations. Chemistry (Weinheim an der Bergstrasse, Germany) 20120109
Synthesis of novel mast cell-stabilising and anti-allergic 1,2,3,4-tetrahydro-1-naphthalenols and related compounds. European journal of medicinal chemistry 20110501
Spectroscopic investigations on Naphthol and Tetrahydronaphthol. A theoretical approach. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20110201
To remove or not to remove? The challenge of extracting the template to make the cavities available in Molecularly Imprinted Polymers (MIPs). International journal of molecular sciences 20110101
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Antitumor agents 269. Non-aromatic ring-A neotanshinlactone analog, TNO, as a new class of potent antitumor agents. Bioorganic & medicinal chemistry letters 20091115
An inner pore residue (Asn406) in the Nav1.5 channel controls slow inactivation and enhances mibefradil block to T-type Ca2+ channel levels. Molecular pharmacology 20061101
Monocyclic and dicyclic hydrocarbons: structural requirements for proximal giant axonopathy. Acta neuropathologica 20060901
Breakdown products on metabolic pathway of degradation of benz[a]anthracene by a ligninolytic fungus. Chemosphere 20060701
Aryltetralol and aryltetralone lignans from Holostylis reniformis. Phytochemistry 20060501
Mode of binding of methyl acceptor substrates to the adrenaline-synthesizing enzyme phenylethanolamine N-methyltransferase: implications for catalysis. Biochemistry 20051227
Sub- and supercritical chiral separation of racemic compounds on columns with stationary phases having different functional groups. Chemical & pharmaceutical bulletin 20051001
Unexpectedly small ortho-oxygen substituent effects on stabilities of benzylic carbocations. Journal of the American Chemical Society 20040818
Dopamine-induced death of PC12 cells is prevented by a substituted tetrahydronaphthalene. Neuropharmacology 20040601
Influence of phenylalanines 77 and 138 on the stereospecificity of aryl sulfotransferase IV. Drug metabolism and disposition: the biological fate of chemicals 20040501
Comparative molecular field analysis of substrates for an aryl sulfotransferase based on catalytic mechanism and protein homology modeling. Journal of medicinal chemistry 20021205
Enantioselective routes to both enantiomers of aryl alcohols with a single catalyst antipode: Ru and Os transfer hydrogenation catalysts. Organic letters 20011115
Evidence against an action of mibefradil at N-type voltage-operated calcium channels. Naunyn-Schmiedeberg's archives of pharmacology 20011101
Properties